Avacta Group Plc (OTCMKTS:AVCTF – Get Free Report) shares traded up 3.3% during mid-day trading on Thursday . The stock traded as high as $0.58 and last traded at $0.58. 1,896 shares were traded during mid-day trading, a decline of 34% from the average session volume of 2,870 shares. The stock had previously closed at $0.56.
Avacta Group Stock Performance
The business’s 50-day simple moving average is $0.66 and its 200 day simple moving average is $0.75.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Featured Stories
- Five stocks we like better than Avacta Group
- Short Selling: How to Short a Stock
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- Using the MarketBeat Dividend Tax Calculator
- Top 3 ETFs to Hedge Against Inflation in 2025
- What is the Shanghai Stock Exchange Composite Index?
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
